Pharmafile Logo
Pharmafocus logo
Advanced Search

Thermo Fisher to become founding sponsor of Momentum Labs

January 17, 2023
Medical Communications

Thermo Fisher Scientific has announced that it has become a founding sponsor of Momentum Labs in Alachua, Florida, US. The …

News

Indonesia begins hearing class-action lawsuit after children’s deaths from cough syrup

January 17, 2023
Medical Communications

An Indonesian court has begun proceedings to hear a class-action lawsuit against health and finance ministries, the drugs regulator and …

News

Green Bioactives appoints experienced biotech leaders Chris Meaney and Andy Hall-Ponselé to expand senior management team

January 17, 2023
Business Services

Edinburgh, Scotland, 17 January 2023 – Green Bioactives Limited (‘GBL’), a world-leader in the discovery, development and sustainable production of …

Appointment

AstraZeneca UK, Qure.ai and Greater Manchester Cancer Alliance Join Forces to Battle Lung Cancer Waiting Times Using Artificial Intelligence (AI) Technology

January 17, 2023
Business Services

London, UK, 13 January 2023 – An initiative to improve earlier diagnosis of lung cancer has been launched by AstraZeneca UK, …

News
Press release

The Scottish Medicines Consortium recommends Merck’s TEPMETKO® (tepotinib) as the first oral MET inhibitor treatment option for advanced NSCLC adult patients with METex14 skipping alterations

January 16, 2023
Business Services

16 January 2023, Feltham (Merck) – Today Merck, a leading science and technology company, announced that following a resubmission to …

News
Press release

Boehringer Ingelheim and 3T Biosciences form $268m partnership to develop next-generation cancer immunotherapies

January 16, 2023
Medical Communications

Germany-based Boehringer Ingelheim and US company 3T Biosciences have entered into a strategic collaboration and licensing agreement to research and …

News

Eli Lilly and AbbVie leave UK VPAS; blow to UK pharma industry

January 16, 2023
Medical Communications

Eli Lilly and AbbVie have announced their departure from the voluntary scheme for branded medicines pricing and access (VPAS), causing …

News

Luye Pharma’s Rykindo® approved by FDA for treatment of schizophrenia and bipolar 1 disorder

January 16, 2023
Research and Development

International pharmaceutical company, Luye Pharma, has announced that Rykindo® has received FDA approval for the treatment of schizophrenia in adult …

News

AstraZeneca’s Tezspire gains CHMP approval for the treatment of severe asthma

January 16, 2023
Research and Development

AstraZeneca has announced that Tezspire (also known as tezepelumab) has received approval from the EMA’s Committee for Medicinal Products for …

News

Poolbeg announces strategic expansion of POLB 001 into oncology

January 16, 2023
Business Services

16 January 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’), a leading infectious disease focused biopharmaceutical …

News
Press release

finnCap Cavendish advises on the sale of MBI Healthcare Technologies to DNV

January 13, 2023
Business Services

London, 9th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised the three …

News
Press release

Pfizer’s COVID-19 vaccine under FDA’s examination following new research into adverse side effects

January 13, 2023
Medical Communications

The FDA, along with Taiwanese medical institutions, have been evaluating Pfizer’s mRNA COVID-19 vaccine, questioning the CDC’s omission of known …

News

Diabeloop and EOFlow team up to develop an automated insulin device

January 13, 2023
Medical Communications

Diabeloop, a medical device company focused on automated diabetes treatment solutions, and South Korea-based EOFlow have joined forces to offer …

News

First patient enrolled in Inari DEFIANCE trial for deep vein thrombosis

January 13, 2023
Research and Development

Inari Medical has announced that the first patient has been enrolled in the DEFIANCE trial. This trial will evaluate the …

News

MediciNova completes enrolment for phase 2 clinical trial of ibudilast to treat recurrent and newly diagnosed glioblastoma

January 13, 2023
Research and Development

Biopharmaceutical company MediciNova has announced that its phase 2 clinical trial to assess MN-166 (ibudilast) for the treatment of recurring …

News

Ajinomoto and Exelixis sign agreement to develop novel ADCs for cancer treatment

January 12, 2023
Research and Development

Ajinomoto Co., a Japanese biotech company providing biopharmaceuticals, has signed a license agreement with Exelixis Inc., an oncology-focused biotech company, …

News

BD showcase new-generation robotic track system for microbiology labs

January 12, 2023
Medical Communications

US-based Becton, Dickinson and Company (BD) has revealed new-generation robotic track system for its BD Kiestra microbiology laboratory solution which …

News

Oramed shares disappointing top-line results from phase 3 trial for type 2 diabetes treatment

January 12, 2023
Research and Development

Clinical stage pharmaceutical company, Oramed Pharmaceuticals, has announced top-line results from its phase 3 randomised, double-blind, placebo-controlled, multicentre trial, which …

News

Alvotech’s golimumab biosimilar phase 1 trial begins

January 12, 2023
Research and Development

Alvotech has announced that it has begun a phase 1 study evaluating the safety, tolerability and pharmacokinetics of its golimumab …

News

Avillion announces US approval of AstraZeneca’s Airsupra (PT027) as new rescue treatment for asthma

January 11, 2023
Business Services

London, UK, 11 January 2023 – Avillion LLP, a drug development company focused on the co-development and financing of pharmaceutical …

News
Press release
The Gateway to Local Adoption Series

Latest content

Five Facts about spinal muscular atrophy

January 28, 2026

Sobi’s Aspaveli receives European Commission approval for treatment of two rare kidney diseases

January 28, 2026

Everdrone appoints David Borkmann as Senior Medical Advisor

January 28, 2026

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026